Catalyst Wire Dossier Catalyst Wire Dossier

DG HEALTH NAPROXEN SODIUM

naproxen sodium · Dolgencorp Inc
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for DG HEALTH NAPROXEN SODIUM, covering 2006-12-19 to 2014-11-12. Get the full timeline:

Most recent: FDA Approved: DG HEALTH NAPROXEN SODIUM — Supplemental Application (Dolgencorp Inc)

See pricing